{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:54:58Z","timestamp":1792086898872,"version":"4.4.0"},"reference-count":42,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,5,1]]},"abstract":"<jats:p>Structural aberrations of the short arm of chromosome 2, mostly resulting in gains of 2p13\u223c16, have recently been described as being highly recurrent in Hodgkin and Reed-Sternberg (HRS) cells of classical Hodgkin lymphoma (cHL). As these gains consistently lead to increased copy numbers of the REL oncogene locus, we investigated the expression of the c-Rel protein in a series of 30 cHL cases with known genomic REL status as determined by comparative genomic hybridization and interphase cytogenetics. Expression of the c-Rel protein was investigated in 26 biopsies by immunohistochemistry. Distinct patterns were observed in HRS cells with no staining, cytoplasmic, and\/or nuclear staining for c-Rel. All 13 samples with additional copies of the REL locus displayed nuclear staining for c-Rel, while 13 cHL samples lacking chromosome 2 (2p) gains displayed a significantly lower proportion or complete absence of HRS cells with nuclear c-Rel expression. Detailed analysis using combined immunophenotyping and interphase cytogenetics of individual HRS cells demonstrated that REL gains correlated with the presence of nuclear c-Rel staining. Additionally, in 2 cHL samples with translocation breakpoints in 2p13\u223c16, nuclear staining of c-Rel was observed; in one of them the staining pattern was indicative of a truncated c-Rel protein. The correlation between structural aberrations involving the REL locus and nuclear c-Rel accumulation in HRS cells qualifies REL as a target gene of the frequent gains in 2p in cHL. The data suggest thatREL aberrations are a genetic mechanism contributing to constitutive nuclear factor (NF)\u2013\u03baB\/Rel activation in cHL.<\/jats:p>","DOI":"10.1182\/blood-2002-08-2577","type":"journal-article","created":{"date-parts":[[2003,4,21]],"date-time":"2003-04-21T17:30:06Z","timestamp":1050946206000},"page":"3681-3686","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":149,"title":["Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma"],"prefix":"10.1182","volume":"101","author":[{"given":"Thomas F. E.","family":"Barth","sequence":"first","affiliation":[{"name":"From the Abteilung fu\u0308r Pathologie des Universita\u0308tsklinikums Ulm, Germany; Institut fu\u0308r Humangenetik, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany; Deutsches Krebsforschungszentrum, Abteilung Molekulare Genetik, Heidelberg, Germany; Pathologisches Institut der Universita\u0308t Heidelberg, Germany; and Institut fu\u0308r Ha\u0308matopathologie, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose\u0301 I.","family":"Martin-Subero","sequence":"additional","affiliation":[{"name":"From the Abteilung fu\u0308r Pathologie des Universita\u0308tsklinikums Ulm, Germany; Institut fu\u0308r Humangenetik, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany; Deutsches Krebsforschungszentrum, Abteilung Molekulare Genetik, Heidelberg, Germany; Pathologisches Institut der Universita\u0308t Heidelberg, Germany; and Institut fu\u0308r Ha\u0308matopathologie, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Joos","sequence":"additional","affiliation":[{"name":"From the Abteilung fu\u0308r Pathologie des Universita\u0308tsklinikums Ulm, Germany; Institut fu\u0308r Humangenetik, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany; Deutsches Krebsforschungszentrum, Abteilung Molekulare Genetik, Heidelberg, Germany; Pathologisches Institut der Universita\u0308t Heidelberg, Germany; and Institut fu\u0308r Ha\u0308matopathologie, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane K.","family":"Menz","sequence":"additional","affiliation":[{"name":"From the Abteilung fu\u0308r Pathologie des Universita\u0308tsklinikums Ulm, Germany; Institut fu\u0308r Humangenetik, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany; Deutsches Krebsforschungszentrum, Abteilung Molekulare Genetik, Heidelberg, Germany; Pathologisches Institut der Universita\u0308t Heidelberg, Germany; and Institut fu\u0308r Ha\u0308matopathologie, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Hasel","sequence":"additional","affiliation":[{"name":"From the Abteilung fu\u0308r Pathologie des Universita\u0308tsklinikums Ulm, Germany; Institut fu\u0308r Humangenetik, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany; Deutsches Krebsforschungszentrum, Abteilung Molekulare Genetik, Heidelberg, Germany; Pathologisches Institut der Universita\u0308t Heidelberg, Germany; and Institut fu\u0308r Ha\u0308matopathologie, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunhild","family":"Mechtersheimer","sequence":"additional","affiliation":[{"name":"From the Abteilung fu\u0308r Pathologie des Universita\u0308tsklinikums Ulm, Germany; Institut fu\u0308r Humangenetik, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany; Deutsches Krebsforschungszentrum, Abteilung Molekulare Genetik, Heidelberg, Germany; Pathologisches Institut der Universita\u0308t Heidelberg, Germany; and Institut fu\u0308r Ha\u0308matopathologie, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza M.","family":"Parwaresch","sequence":"additional","affiliation":[{"name":"From the Abteilung fu\u0308r Pathologie des Universita\u0308tsklinikums Ulm, Germany; Institut fu\u0308r Humangenetik, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany; Deutsches Krebsforschungszentrum, Abteilung Molekulare Genetik, Heidelberg, Germany; Pathologisches Institut der Universita\u0308t Heidelberg, Germany; and Institut fu\u0308r Ha\u0308matopathologie, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lichter","sequence":"additional","affiliation":[{"name":"From the Abteilung fu\u0308r Pathologie des Universita\u0308tsklinikums Ulm, Germany; Institut fu\u0308r Humangenetik, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany; Deutsches Krebsforschungszentrum, Abteilung Molekulare Genetik, Heidelberg, Germany; Pathologisches Institut der Universita\u0308t Heidelberg, Germany; and Institut fu\u0308r Ha\u0308matopathologie, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[{"name":"From the Abteilung fu\u0308r Pathologie des Universita\u0308tsklinikums Ulm, Germany; Institut fu\u0308r Humangenetik, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany; Deutsches Krebsforschungszentrum, Abteilung Molekulare Genetik, Heidelberg, Germany; Pathologisches Institut der Universita\u0308t Heidelberg, Germany; and Institut fu\u0308r Ha\u0308matopathologie, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mo\u0308ller","sequence":"additional","affiliation":[{"name":"From the Abteilung fu\u0308r Pathologie des Universita\u0308tsklinikums Ulm, Germany; Institut fu\u0308r Humangenetik, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany; Deutsches Krebsforschungszentrum, Abteilung Molekulare Genetik, Heidelberg, Germany; Pathologisches Institut der Universita\u0308t Heidelberg, Germany; and Institut fu\u0308r Ha\u0308matopathologie, Universita\u0308tsklinikum Schleswig-Holstein, Campus Kiel, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111822250756100_B1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/annonc\/13.S1.11","article-title":"Biology of Hodgkin's lymphoma.","volume":"13(suppl 1)","author":"Ku\u0308ppers","year":"2002","journal-title":"Ann Oncol."},{"key":"2019111822250756100_B2","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood.V95.4.1443.004k55_1443_1450","article-title":"Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription.","volume":"95","author":"Marafioti","year":"2000","journal-title":"Blood."},{"key":"2019111822250756100_B3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1084\/jem.191.2.207","article-title":"The molecular and cellular origins of Hodgkin's disease.","volume":"191","author":"Staudt","year":"2000","journal-title":"J Exp Med."},{"key":"2019111822250756100_B4","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2002-01-0099","article-title":"The role of cytokines in classical Hodgkin lymphoma.","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood."},{"key":"2019111822250756100_B5","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1172\/JCI119849","article-title":"Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.","volume":"100","author":"Bargou","year":"1997","journal-title":"J Clin Invest."},{"key":"2019111822250756100_B6","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1182\/blood.V97.9.2798","article-title":"Constitutive NF-\u03baB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin\/Reed-Sternberg cells.","volume":"97","author":"Hinz","year":"2001","journal-title":"Blood."},{"key":"2019111822250756100_B7","first-page":"549","article-title":"Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells.","volume":"60","author":"Joos","year":"2000","journal-title":"Cancer Res."},{"key":"2019111822250756100_B8","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood.V99.4.1381","article-title":"Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2.","volume":"99","author":"Joos","year":"2002","journal-title":"Blood."},{"key":"2019111822250756100_B9","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood.V99.4.1474","article-title":"Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.","volume":"99","author":"Martin-Subero","year":"2002","journal-title":"Blood."},{"key":"2019111822250756100_B10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","article-title":"The NF-kappa B and I kappa B proteins: new discoveries and insights.","volume":"14","author":"Baldwin","year":"1996","journal-title":"Annu Rev Immunol."},{"key":"2019111822250756100_B11","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.1038\/sj.onc.1203237","article-title":"The Rel\/NF-kappaB signal transduction pathway: introduction.","volume":"18","author":"Gilmore","year":"1999","journal-title":"Oncogene."},{"key":"2019111822250756100_B12","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1038\/sj.onc.1203221","article-title":"Aberrant rel\/nfkb genes and activity in human cancer.","volume":"18","author":"Rayet","year":"1999","journal-title":"Oncogene."},{"key":"2019111822250756100_B13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.cb.10.110194.002201","article-title":"Structure, regulation and function of NF-kappa B.","volume":"10","author":"Siebenlist","year":"1994","journal-title":"Annu Rev Cell Biol."},{"key":"2019111822250756100_B14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s001090050078","article-title":"The NF-kappa B\/Rel and I kappa B gene families: mediators of immune response and inflammation.","volume":"74","author":"Wulczyn","year":"1996","journal-title":"J Mol Med."},{"key":"2019111822250756100_B15","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1038\/sj.onc.1202893","article-title":"Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha.","volume":"18","author":"Cabannes","year":"1999","journal-title":"Oncogene."},{"key":"2019111822250756100_B16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1084\/jem.191.2.395","article-title":"Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma.","volume":"191","author":"Jungnickel","year":"2000","journal-title":"J Exp Med."},{"key":"2019111822250756100_B17","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/sj.onc.1201735","article-title":"Defective IkappaBalpha in Hodgkin cell lines with constitutively active NF-kappaB.","volume":"16","author":"Wood","year":"1998","journal-title":"Oncogene."},{"key":"2019111822250756100_B18","volume-title":"Tumours of Haematopoietic and Lymphoid Tissues.","author":"Jaffe","year":"2001"},{"key":"2019111822250756100_B19","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/emboj\/16.6.1413","article-title":"I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity.","volume":"16","author":"Whiteside","year":"1997","journal-title":"EMBO J."},{"key":"2019111822250756100_B20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0092-8674(92)90353-E","article-title":"The precursor of NF-kappa B p50 has I kappa B-like functions.","volume":"71","author":"Rice","year":"1992","journal-title":"Cell."},{"key":"2019111822250756100_B21","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/MCB.18.5.2640","article-title":"The N-terminal domain of IkappaB alpha masks the nuclear localization signal(s) of p50 and c-Rel homodimers.","volume":"18","author":"Latimer","year":"1998","journal-title":"Mol Cell Biol."},{"key":"2019111822250756100_B22","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1182\/blood.V98.12.3413","article-title":"The BCL11 gene family: involvement of BCL11A in lymphoid malignancies.","volume":"98","author":"Satterwhite","year":"2001","journal-title":"Blood."},{"key":"2019111822250756100_B23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-642-59918-7_9","article-title":"Classical and molecular cytogenetics of tumor cells.","volume-title":"Diagnostic Cytogenetics.","author":"Schlegelberger","year":"1999"},{"key":"2019111822250756100_B24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0002-9440(10)64197-1","article-title":"Multicolor-FICTION: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses.","volume":"161","author":"Martin-Subero","year":"2002","journal-title":"Am J Pathol."},{"key":"2019111822250756100_B25","first-page":"72","article-title":"Cytogenetic findings and results of combined immunophenotyping and karyotyping in Hodgkin's disease.","volume":"8","author":"Schlegelberger","year":"1994","journal-title":"Leukemia."},{"key":"2019111822250756100_B26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/gcc.10051","article-title":"Genomic organization and expression of the rearranged REL proto-oncogene in the human B-cell lymphoma cell line RC-K8.","volume":"34","author":"Kalaitzidis","year":"2002","journal-title":"Genes Chromosomes Cancer."},{"key":"2019111822250756100_B27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1034\/j.1600-065X.2000.00615.x","article-title":"Rel\/NF-kappaB transcription factors: key mediators of B-cell activation.","volume":"176","author":"Gugasyan","year":"2000","journal-title":"Immunol Rev."},{"key":"2019111822250756100_B28","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4299::AID-IMMU4299>3.0.CO;2-Y","article-title":"c-Rel is essential for B lymphocyte survival and cell cycle progression.","volume":"28","author":"Tumang","year":"1998","journal-title":"Eur J Immunol."},{"key":"2019111822250756100_B29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature."},{"key":"2019111822250756100_B30","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1182\/blood.V90.3.1168","article-title":"BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma.","volume":"90","author":"Monni","year":"1997","journal-title":"Blood."},{"key":"2019111822250756100_B31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1006\/scbi.1999.0126","article-title":"Oncogene amplification in solid tumors.","volume":"9","author":"Schwab","year":"1999","journal-title":"Semin Cancer Biol."},{"key":"2019111822250756100_B32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1200\/JCO.2000.18.2.267","article-title":"HER-2\/neu amplification in benign breast disease and the risk of subsequent breast cancer.","volume":"18","author":"Stark","year":"2000","journal-title":"J Clin Oncol."},{"key":"2019111822250756100_B33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00001622-200109000-00002","article-title":"Molecular features of B-cell lymphoma.","volume":"13","author":"Siebert","year":"2001","journal-title":"Curr Opin Oncol."},{"key":"2019111822250756100_B34","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1182\/blood.V96.3.808.015k30_808_822","article-title":"The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies.","volume":"96","author":"Willis","year":"2000","journal-title":"Blood."},{"key":"2019111822250756100_B35","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/gcc.1150","article-title":"Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract.","volume":"31","author":"Barth","year":"2001","journal-title":"Genes Chromosomes Cancer."},{"key":"2019111822250756100_B36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1182\/blood.V87.1.25.25","article-title":"REL proto-oncogene is frequently amplified in extra-nodal diffuse large cell lymphoma.","volume":"87","author":"Houldsworth","year":"1996","journal-title":"Blood."},{"key":"2019111822250756100_B37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/1098-2264(2001)9999:9999<::AID-GCC1105>3.0.CO;2-I","article-title":"Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line.","volume":"30","author":"Bentz","year":"2001","journal-title":"Genes Chromosomes Cancer."},{"key":"2019111822250756100_B38","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.1365-2141.2000.02352.x","article-title":"The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma.","volume":"111","author":"Goff","year":"2000","journal-title":"Br J Haematol."},{"key":"2019111822250756100_B39","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med."},{"key":"2019111822250756100_B40","first-page":"302","article-title":"Nuclear expression of Rel correlates with gene amplification in diffuse large B-cell lymphomas (DLBCL) [abstract].","volume":"98","author":"Donelly","year":"2001","journal-title":"Blood."},{"key":"2019111822250756100_B41","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1093\/emboj\/cdf389","article-title":"Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappaB.","volume":"21","author":"Mathas","year":"2002","journal-title":"EMBO J."},{"key":"2019111822250756100_B42","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1182\/blood.V99.2.618","article-title":"Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/9\/3681\/1257620\/h80903003681.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/9\/3681\/1257620\/h80903003681.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:25:23Z","timestamp":1574133923000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/9\/3681\/105868\/Gains-of-2p-involving-the-REL-locus-correlate-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,1]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,5,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-08-2577","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2003,5,1]]}}}